KEGG   DRUG: EfalizumabHelp
Entry
D03959                      Drug                                   

Name
Efalizumab (USAN/INN);
Raptiva (TN)
Remark
ATC code: L04AA21
Efficacy
Antipsoriatic, Immunosuppressant, Anti-CD11a antibody
Comment
Monoclonal antibody
Treatment of transplant rejections
Target
ITGAL (CD11A) [HSA:3683] [KO:K05718]
  Pathway
hsa04514  Cell adhesion molecules (CAMs)
hsa04650  Natural killer cell mediated cytotoxicity
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AA Selective immunosuppressants
     L04AA21 Efalizumab
      D03959  Efalizumab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: other families
   Integrins
    ITGAL (CD11A)
     D03959  Efalizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 214745-43-4
PubChem: 47205946
DrugBank: DB00095

» Japanese version   » Back

DBGET integrated database retrieval system